TI
CKPT

Telemetry Investments’s Checkpoint Therapeutics CKPT Stock Holding History

Telemetry Investments’s Portfolio CKPT Stock Details CKPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$51K Buy
+10,000
New +$72K 0.08% 100
2022
Q2 		– Sell
-4,500
Closed -$80K – 179
2022
Q1 		$80K Sell
4,500
-2,000
-31% -$43K 0.13% 111
2021
Q4 		$202K Sell
6,500
-500
-7% -$16.6K 0.26% 114
2021
Q3 		$231K Buy
+7,000
New +$207K 0.31% 100

Other funds holding CKPT

TC
TwinBeech Capital Purchase, New York $553M AUM 0.21% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PAM
PVG Asset Management Golden, Colorado $173M AUM 64.51% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
PAS
Park Avenue Securities New York $16B AUM 26.77% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Telemetry Investments's CKPT Position: Q4 2022 in Review

Telemetry Investments opened a new position in Checkpoint Therapeutics (CKPT) in Q4 2022: 10,000 shares worth $51K. The stake represents 0.08% of the portfolio and ranks #100 among its holdings. This is a return to the name: Telemetry Investments previously reported a position in CKPT as recently as Q1 2022.

Telemetry Investments first reported a position in CKPT in Q3 2021 and has held it in 4 quarters since. The position peaked at $231K in Q3 2021. 39 funds tracked by Wall St. Rank hold CKPT as of Q4 2022.

  • Telemetry Investments held 10,000 shares of Checkpoint Therapeutics worth $51K as of Q4 2022.
  • Checkpoint Therapeutics was a new Telemetry Investments position in Q4 2022.
  • Checkpoint Therapeutics made up 0.08% of Telemetry Investments's portfolio in Q4 2022, its #100 holding.
  • Telemetry Investments first reported a position in Checkpoint Therapeutics in Q3 2021 and has held it in 4 quarters since.
  • Telemetry Investments's Checkpoint Therapeutics position peaked at $231K in Q3 2021.
  • 39 funds tracked by Wall St. Rank held Checkpoint Therapeutics as of Q4 2022.

Based on Telemetry Investments's 13F filing for Q4 2022, filed 14 Feb 2023.